CD79A and Miyoshi myopathy: Forty-three healthy controls and forty-one MM patients (MM subtype: n=24 IgG kappa, n=7 light chain MM, n=5 IgA kappa, n=5 IgG/IgA lambda) with prior or ongoing Lena maintenance therapy were included.